Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.20 USD
-0.04 (-1.79%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.20 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Taysha Gene Therapies, Inc. [TSHA]
Reports for Purchase
Showing records 1 - 20 ( 25 total )
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
GAN Data Continues to Paint Compelling Picture for TSHA-120
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Gene Therapy 101: Deliver the Target, Express the Protein - TSHA on Right Path
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Angelman Syndrome Investor Event - Key Highlights, Takeaways
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Discovery Collaboration Continues to Create Optionality for TSHA
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Investor Event Showcases Earlier-Stage Efforts in Rett Syndrome
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
CLN1 Disease Investor Event - Key Highlights, Takeaways
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Taking A Closer Look Under The Hood - Manufacturing Day Highlights
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L